3 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
Follow CAT-8015 Immunotoxin: new trials by email Literature Review of CAT-8015 Immunotoxin trials Research Report on CAT-8015 Immunotoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease Immunotoxin therapy, CAT-8015 Immunotoxin, Biological therapy - Leukemia, Non-Hodgkin's Lymphoma | Phase 1 | Unknown | Cambridge Antibody Technology | 50 | 2007-08-01 | 2007-08-14 |
| Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease Immunotoxin therapy, CAT-8015 Immunotoxin, Biological therapy - Leukemia, Hairy Cell Leukemia | Phase 1 | Unknown | Cambridge Antibody Technology | 40 | 2007-04-01 | 2007-04-18 |
| Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease Immunotoxin therapy, CAT-8015 immunotoxin, Biological therapy - Leukemia | Phase 1 | Unknown | Cambridge Antibody Technology | 50 | 2007-03-01 | 2007-04-17 |
Leukemia (3) · Recurrence (2) · Leukemia, Hairy Cell (1) · Lymphoma, Non-Hodgkin (1)
Cambridge Antibody Technology (3)
Poland (3) · United States (3) · United Kingdom (1)